Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Xianquan Zhan, Jianping Liu and Zhuchu Chen
ScientificTracks Abstracts: J Proteomics Bioinform
Xianquan Zhan received his undergraduate and graduate training at the West China University of Medical Sciences, Chengdu, China, where he spent 10 years, and obtained his B.M./M.D. degree in preventive medicine in 1994, M.S. degree in occupational epidemiology in 1996, and Ph.D. degrees in molecular toxicology in 1999. He received his post-doctoral training in oncology and cancer proteomics for two years at the Cancer Research Institute of Human Medical University, Changsha, China. In 2001, he went to the University of Tennessee Health Science Center (UTHSC), Memphis, Tennessee, USA, where he was a post-doctoral researcher (mass spectrometry, proteomics) supervised by Prof. Dominic M. Desiderio in the Charles B. Stout Neuroscience Mass Spectrometry Laboratory in the Department of Neurology. Then, he was appointed as an Assistant Professor of Neurology, UTHSC in 2005. He moved to the Cleveland Clinic (Cleveland, Ohio, USA) as a Project Scientist/Staff in 2006 where he focused on the studies of eye disease proteomics and biomarkers. In the end of 2007, he returned to UTHSC as an Assistant Professor of Neurology, engaging in proteomics and biomarker studies of lung diseases and brain tumors, and initiating the studies of predictive, preventive, and personalized medicine in cancer. In July 2010, he was promoted to Associate Professor of Neurology, UTHSC. Currently, he is a Distinguished Professor of disease proteomics and structural biology, Xiangya Hospital, Central South University, Changsha, China, the National Representative in China of European Association for Predictive, Preventive, and Personalized Medicine (EPMA), Associate Editor of BMC Genomic, and Associate Editor of BMC Medical Genomics. He has published 50+ peer-reviewed research articles including 30+ articles in the field of disease proteomics and transcriptomics, 4 book chapters, and 1 US patent. His current main research interest focuses on the studies of disease proteomics/biomarkers and structural biology, and the development and use of modern ?omics techniques including proteomics for cancer predictive, preventive, and personalized medicine.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals